To further accelerate its growth, xG Health Solutions™ today appointed Andrew Blackmon as its chief sales and business development officer.
The full merger and integration of Lewistown Hospital into Geisinger Health System has received final approval from the Pennsylvania Attorney General and the Pennsylvania Department of Health.
Geisinger Health System’s Genomic Medicine Institute has been approved to receive a $1.4 million research award from the Patient-Centered Outcomes Research Institute (PCORI) to study how best to share genomic lab results with patients. The study is part of a portfolio of projects that will advance the field of patient-centered comparative effectiveness research and provide patients with information that will help them make better-informed decisions about their care.
Geisinger Health System has announced the formation of the Geisinger Institute for Advanced Application (GIAA) that will utilize Geisinger’s unique model and cross-disciplinary expertise to make significant, tangible contributions to improving health care quality and outcomes for patients, providers, payers and employers.
Four Geisinger Health System researchers have taken center stage in the national arena of genomics thanks to new funding from the National Human Genome Research Institute (NHGRI), an arm of the U.S. National Institutes of Health (NIH).
Insights of several research teams actively engaged in integrating genomic medicine into the electronic health record are featured in the October 2013 issue of Genetics in Medicine.
Researchers from Geisinger’s Henry Hood Center for Health Research and Johns Hopkins Bloomberg School of Public Health have for the first time found an association between living in proximity to high-density livestock production and community-acquired infections with methicillin-resistant Staphylococcus aureus, commonly known as MRSA.
Geisinger researchers have developed a simple scoring system (DiaRem), based on four readily available preoperative patient characteristics, that can predict which candidates for gastric bypass surgery are likely to achieve Type 2 diabetes remission within 5 years. A predictive model is likely to help patients and clinicians better manage the disease and could even save lives.
Geisinger Health System (GHS), Danville, Pa., and Holy Spirit Health System, Camp Hill, Pa., announced today the signing of a letter of intent to explore ways the healthcare organizations can work together to benefit healthcare in southcentral Pennsylvania.
Residents of California’s Central Coast will soon reap the benefits of a newly formed healthcare partnership that aims to advance quality while driving down costs thanks to an innovative healthcare delivery model known as the patient-centered medical home.
To support its rapid growth, xG Health Solutions’™ Chief Executive Officer Earl Steinberg, MD, today announced the addition of four executives to his leadership team.
A recent report by The Hospital and Healthsystem Association of Pennsylvania (HAP) indicates Geisinger Health System has an annual $6.1 billion positive impact on the local, regional and statewide economy.
Thursday’s Supreme Court ruling that human genes cannot be patented is a major victory for patients.
Findings could have implications in treatment of hereditary neuropathy.
Geisinger Health System announced plans to partner with Indivumed, a leading provider of services enabling individualized cancer therapy.
Health system embraces OpenNotes® to get patients involved in care.
Study will examine how residents in New Jersey counties have fared since natural disaster.
Story ideas and photo opportunities for May.
Facility a national model for early diagnosis, treatment for children with developmental disorders.
John M. Inadomi, M.D., of the University of Washington, and Robert F. Murphy, Ph.D., of Carnegie Mellon University, will serve as scientific advisors to Cernostics. They will assist Cernostics, a life science firm that develops and commercializes advanced cancer diagnostic tests, to oversee efforts to develop a test that predicts the risk of esophageal cancer in patients with severe gastro-esophageal reflux disease (GERD) and Barrett’s Esophagus.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right